Stanford Pediatric Grand Rounds: Next Level Pediatric Inflammatory Bowel Disease |
|
Next Level Pediatric Inflammatory Bowel Disease: Moving Toward Precision Dosing of Biologic Therapy
Presented by Michael Rosen, MD, MSCI Stanford School of Medicine Pediatric inflammatory bowel disease (IBD) is on the rise, and anti-TNF biologic drugs are the most common and effective treatment. This talk will highlight patient- and disease-related variation in anti-TNF drug pharmacokinetics, and how proactive therapeutic drug monitoring and precision dosing may be used to optimize treatment and outcomes. |